Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | OXTR | P30559 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | ITGAL | P20701 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3074959 | 0.78 | MAOA (0.50) | MAOAMAOBOXTRABCG2ITGB2 | |
| SCHEMBL574574 | 0.77 | MAOA (0.48) | MAOAMAOBOXTRABCG2ITGB2 | |
| SCHEMBL2075820 | 0.75 | MAOA (0.46) | MAOAMAOBOXTRABCG2ITGB2 | |
| SCHEMBL584704 | 0.75 | MAOA (0.46) | MAOAMAOBOXTRABCG2ITGB2 | |
| SCHEMBL2596861 | 0.75 | MAOA (0.46) | MAOAMAOBOXTRABCG2ITGB2 | |
| SCHEMBL5181287 | 0.75 | MAOA (0.46) | MAOAMAOBOXTRABCG2ITGB2 | |
| SCHEMBL15284925 | 0.75 | MAOA (0.46) | MAOAMAOBOXTRABCG2ITGB2 | |
| SCHEMBL3235013 | 0.75 | MAOA (0.46) | MAOAMAOBOXTRABCG2ITGB2 | |
| SCHEMBL1871104 | 0.75 | MAOA (0.46) | MAOAMAOBOXTRABCG2ITGB2 | |
| SCHEMBL3783560 | 0.73 | MAOA (0.41) | MAOAMAOBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4396184-B1 | DIFUNCTIONAL BIO-BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | JONES PAUL (GB) | 2025-09-17 | — | — | EP | claimed |
| EP-4565580-A1 | ORTHO-SUBSTITUTED DIFUNCTIONAL BIO-BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | Jones, Paul (GB) | 2025-06-11 | — | — | EP | claimed |
| US-20240368148-A1 | DIFUNCTIONAL BIO-BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | JONES PAUL (GB) | 2024-11-07 | — | — | US | claimed |
| EP-4396184-A1 | DIFUNCTIONAL BIO-BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | Jones, Paul (GB) | 2024-07-10 | — | — | EP | claimed |
| WO-2024028605-A1 | ORTHO-SUBSTITUTED DIFUNCTIONAL BIO-BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | JONES PAUL (GB) | 2024-02-08 | — | — | WO | claimed |
| CN-113388092-B | Preparation and application of fluorine-containing benzoxazine epoxy resin copolymer with low dielectric constant | 济南大学 | 2023-01-03 | — | — | CN | claimed |
| WO-2022243655-A1 | DIFUNCTIONAL BIO-BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | JONES PAUL (GB) | 2022-11-24 | — | — | WO | claimed |
| CN-113388092-A | Preparation and application of fluorine-containing benzoxazine epoxy resin copolymer with low dielectric constant | 济南大学 | 2021-09-14 | — | — | CN | claimed |
| EP-2231743-B1 | CURABLE BENZOXAZINE MACROMONOMERS, THEIR PREPARATION AND CURED PRODUCTS THEREOF | HENKEL AG & CO KGAA (DE) | 2019-05-22 | — | — | EP | claimed |
| US-8759443-B2 | Curable benzoxazine-based compositions, their preparation and cured products thereof | HENKEL AG & CO. KGAA (DE) | 2014-06-24 | — | — | US | claimed |
| US-8168743-B2 | Curable benzoxazine macromonomers, their preparation and cured products | HENKEL AG & CO. KGAA (DE) | 2012-05-01 | — | — | US | claimed |
| US-20100210787-A1 | CURABLE BENZOXAZINE MACROMONOMERS, THEIR PREPARATION AND CURED PRODUCTS | HENKEL AG & CO. KGAA (DE) | 2010-08-19 | — | — | US | claimed |
| EP-0434440-B1 | Benzoxazine derivatives, benzothiazine derivatives and herbicides comprising the same | SUNTORY LTD (JP) | 1995-09-20 | — | — | EP | claimed |
| EP-4396184-B1 | DIFUNCTIONAL BIO-BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | JONES PAUL (GB) | 2025-09-17 | — | — | EP | disclosed |
| EP-4565580-A1 | ORTHO-SUBSTITUTED DIFUNCTIONAL BIO-BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | Jones, Paul (GB) | 2025-06-11 | — | — | EP | disclosed |
| US-20240368148-A1 | DIFUNCTIONAL BIO-BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | JONES PAUL (GB) | 2024-11-07 | — | — | US | disclosed |
| WO-1997028167-A1 | 2-SUBSTITUTED AMINO AND THIO ALKYL BENZOXAZINE ANTIMICROBIAL AGENTS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1997-08-07 | — | — | WO | disclosed |
| EP-0434440-B1 | Benzoxazine derivatives, benzothiazine derivatives and herbicides comprising the same | SUNTORY LTD (JP) | 1995-09-20 | — | — | EP | disclosed |
| US-5141551-A | BENZOXAZINE DERIVATIVE AND BENZOTHIAZINE DERIVATIVE AND HERBICIDE COMPRISING THE SAME AS ACTIVE INGREDIENT | SUNTORY LIMITED (JP) | 1992-08-25 | — | — | US | disclosed |
| EP-0434440-A1 | Benzoxazine derivatives, benzothiazine derivatives and herbicides comprising the same | SUNTORY LIMITED (JP) | 1991-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368148-A1 | DIFUNCTIONAL BIO-BENZOXAZINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | CYP4F12, CYP4X1, COASY | MAOA 65/4885MAOB 44/4885OXTR 977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.